A recent study published in JAMA Oncology suggests that the ideal duration of hormone therapy for patients with localized prostate cancer may depend on a patients’ individual cancer risk, allowing physicians to tailor treatment plans and…
Category: 6. Health
-

New Vaccine Candidate Shows Long-Lasting Protection Against Crimean-Congo Hemorrhagic Fever
Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne zoonotic viral disease that presents a formidable challenge to global health given its high case-fatality rate, broad endemic geography, and lack of widely approved pharmacologic or…
Continue Reading
-

To persist, memories surf molecular waves from thalamus to cortex
Memories are avid travelers: After they form in the hippocampus, they pass through intermediate regions such as the thalamus before finally stabilizing in the cortex. Yet not all memories survive this journey and become consolidated….
Continue Reading
-
How the Brain Chooses What to Remember and What to Forget – SciTechDaily
- How the Brain Chooses What to Remember and What to Forget SciTechDaily
- Your memories are governed by hidden timers inside your brain The Rockefeller University
- Thalamocortical transcriptional gates coordinate memory stabilization Nature
- To…
Continue Reading
-

Study: Some suicide cases had no typical prior warning signs
Researchers said people who die by suicide without showing prior warning signs, such as suicidal thoughts, may have different underlying risk factors. File Photo by Yuri Kochetkov/EPA
For many families who lose someone to suicide, the same…
Continue Reading
-
Finerenone shows superior survival and kidney protection over spironolactone in diabetic kidney disease – Medical Xpress
- Finerenone shows superior survival and kidney protection over spironolactone in diabetic kidney disease Medical Xpress
- Cardiovascular Outcomes and Hyperkalemia Risk in Patients With Diabetes, Chronic Kidney Disease and Heart Failure: A Real-World…
Continue Reading
-

New CAR T Cells Target Glioblastoma Tumor Microenvironment Protein
Credit: Tonpor Kasa/Getty Images Scientists at the University of Geneva (UNIGE) and the Geneva University Hospital (HUG) have engineered a new CAR T cell therapy approach that can destroy glioblastoma cells. The new…
Continue Reading
-

Study Finds Uneven Burden of Brain and Nervous System Cancers in the U.S.
Ariz Keshwani, ’21 BA, ’22 MPH, a Feinberg medical student, was a co-author of the study. A new nationwide study has revealed striking differences in how brain and nervous system cancers affect Americans depending on where they live, as…
Continue Reading
-

Alveolar Soft part Sarcoma in a 44-year-old female: A case from Uganda
Introduction
Alveolar Soft Part Sarcoma (ASPS) is a rare and enigmatic soft tissue sarcoma (STS) of indeterminate histogenesis, accounting for fewer than 1% of all STS diagnoses.1,2 Since its initial characterization by Christopherson et al in…
Continue Reading
-

Rare inherited variants shape risk and outcomes in pediatric brain and spinal cord tumors
Researchers at Children’s Hospital of Philadelphia (CHOP) and Children’s National Hospital in Washington D.C. are uncovering how rare inherited genetic variants contribute to the development of brain and spinal cord tumors in…
Continue Reading
